Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Perfect

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2016
Isavuconazole Treatment of Cryptococcosis and Dimorphic MycosesGeorge R Thompson, Adrian Rendon, Rodrigo Ribeiro Dos Santos, et al.
Mbio|April 15, 2024
A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infectionJulia R Palmucci, Blake E Sells, Charles D Giamberardino, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Plos Pathogens|May 19, 2018
Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulatorsBenjamin Hommel, Liliane Mukaremera, Radames J B Cordero, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
Msphere|November 22, 2019
Regulatory Mechanism of the Atypical AP-1-Like Transcription Factor Yap1 in Cryptococcus neoformansYee-Seul So, Shinae Maeng, Dong-Hoon Yang, et al.
The Journal of Infectious Diseases|August 7, 2020
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research ConsortiumMelissa D Johnson, Russell E Lewis, Elizabeth S Dodds Ashley, et al.
Mbio|December 5, 2019
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of ResistanceWilliam Hope, Neil R H Stone, Adam Johnson, et al.
Mbio|March 9, 2017
Microevolution of Serial Clinical Isolates of <i>Cryptococcus neoformans</i> var. <i>grubii</i> and <i>C. gattii</i>Yuan Chen, Rhys A Farrer, Charles Giamberardino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii InfectionsJohn W Baddley, Sharon C-A Chen, Carrie Huisingh, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2016
Isavuconazole Treatment of Cryptococcosis and Dimorphic MycosesGeorge R Thompson, Adrian Rendon, Rodrigo Ribeiro Dos Santos, et al.
Mbio|April 15, 2024
A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infectionJulia R Palmucci, Blake E Sells, Charles D Giamberardino, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Plos Pathogens|May 19, 2018
Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulatorsBenjamin Hommel, Liliane Mukaremera, Radames J B Cordero, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
Msphere|November 22, 2019
Regulatory Mechanism of the Atypical AP-1-Like Transcription Factor Yap1 in Cryptococcus neoformansYee-Seul So, Shinae Maeng, Dong-Hoon Yang, et al.
The Journal of Infectious Diseases|August 7, 2020
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research ConsortiumMelissa D Johnson, Russell E Lewis, Elizabeth S Dodds Ashley, et al.
Mbio|December 5, 2019
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of ResistanceWilliam Hope, Neil R H Stone, Adam Johnson, et al.
Mbio|March 9, 2017
Microevolution of Serial Clinical Isolates of <i>Cryptococcus neoformans</i> var. <i>grubii</i> and <i>C. gattii</i>Yuan Chen, Rhys A Farrer, Charles Giamberardino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii InfectionsJohn W Baddley, Sharon C-A Chen, Carrie Huisingh, et al.
Pageof 33